Official UK Store

News

Clinical Research

Over the past 27 years, Lyprinol has employed the services of leading international scientific institutions and individuals to test the product’s safety, its effectiveness and its strength and its comparison to other products.

Lyprinol’s unique formulation is now supported and tested with over 30 clinical trails.

In the News section below you will find some of the latest news stories concerning these trials that are grabbing the headlines.

News

Lyprinol Original and Arthritis

Lyprinol Original and Arthritis

By Tom Hutchinson

If you are 40 years old you can still consider yourself young, and I’m not just saying that to boost your ego; the average life expectancy in the UK is now just over 81 years old. 

Maybe it depends whether your glass is half full or half empty as to whether you agree with me or not but regardless, around the age of 40 we do start to accept the fact that we’re no longer a spring chicken. The slightest pain or stiffness in one of our joints now bring with it a sense that it could be the beginning of something more serious. 

If you feel any stiffness, tightness, burning or consistent aches in any of your joints you need to take the necessary steps to heal yourself right away, regardless of your age! If left untreated it is likely that the pain and stiffness will persist and could lead to arthritis.

Now, arthritis is itself not a single disease, indeed there are over 100 different types and they can affect the body in different ways, but the most common is a degenerative form called Osteoarthritis. 

There are nearly 9 million people suffering from Osteoarthritis in the UK and is likely the one you think about when people say arthritis – where cartilage is worn away around the joints causing pain and can deteriorate to chronic levels where bone rubs against bone.

Nasty, painful and unpleasant.

On top of this, the most commonly affects joints are in your hands, spine, knees and hips, which means that if it is left untreated it can grateful effect your quality of life in a very negative way.

Osteoarthritis is sometimes known as “wear and tear” arthritis because it usually occurs around middle age after we’ve given our bodies a battering through life, intentionally or not, and neglected to look after it. Unfortunately it could also be hereditary and it is more common in women than men. Sorry ladies.

Once your joint becomes inflamed it becomes stiff and painful as your cartilage rubs and deteriorates (not a pretty picture, but hold on the good part is coming) and the best way to deal with this condition is to combat the inflammation around the joint in question.

As there is no cure for arthritis the most common treatments suggested are focused around lifestyle factors such as regular exercise and losing weight. As is the way with modern medicine there are a host of pills to pop that help with the pain, but there is a common supplement that many sufferers turn to instead.

Common sights from studies have shown that fish oil helps to reduce the pain for sufferers of Osteoarthritis. The reason they are so effective is because of the omega-3 fatty acids found in them, specifically EPA and DHA. 

These guys have hard to pronounce names (Eicosapentaenoic acid, Docosahexaenoic acid) but their functions are simple: they help to reduce inflammation. This is key because, unlike conventional painkillers, they target the problem at the source.

Naturally, things are improved faster and faster in modern medicine and fish oil has been around as a supplement for a while. Maybe it’s time for a new kid on the block. One of the latest discoveries is that of the oil extracted from Green-Shelled Mussels found around the coast of New Zealand. 

You can think of their oil as a super-charged version of conventional fish oil because they contain the healthy omega-3 fatty acids as well, but these ones in particular are widely considered to come from one of the best natural sources. 

In studies, this oil extracted from the mussels has been shown to reduce joint pain by 89% and improved the quality of life in 91% of the participants. With over 70% of Osteoarthritis sufferers in constant pain, this was a substantial breakthrough in the treatment of this disease.


Because of their incredible inflammatory products, Lyprinol has used this extract as the basis for their unique formulation of omega-3 fatty acids. This formula has been tested and is now backed by over 30 clinical trails that have taken place over the last 27 years.

The product, itself called Lyprinol Original, has been shown to effectively inhibit the inflammatory process in the body in as little as 4 weeks. When comparing the effectiveness of Lyprinol Original to other similar treatments the numbers are astounding:

  • 100 time more potent than EPA Max (fish oil)
  • 175 time more potent than Salmon Oil
  • 200 time more potent than Flax Oil.

What makes this fish oil supplement so much better than the rest? Scientifically speaking, Lyprinol Original contains additional lipids only found in the Green Lipped Mussel referred to as PCSC-524TM that does the heavy lifting for inflammation. But there’s some extra stuff I know you’ll really like too.

The extraction process is gentle, meaning that the mussel is left in tact and all of the protein or carbohydrates that cause allergies are left on it. Translation: Lyprinol Original is even suitable for people with shellfish intolerances!

Because of their strength, Lyprinol Original tablets are much smaller than the usually large and hard-to-swallow fish oil tablets. They also don’t leave any of the unpleasant side effects you may be used to like fishy breath, upset stomach or greasy stools.

All in all, the unique formula in Lyprinol Original has created a product that blows similar fish oil supplements out of the water (if you pardon the pun) and could quite literally change your life. 

Whether you are starting to feel a few more aches and pains than you’re normally used to or if you’ve been suffering from Osteoarthritis for years already it could be time for you to reach for some Lyprinol Original next time pain and inflammation strikes.

For more information on Green Lipped Mussels read this article here:

https://yumove.co.uk/blogs/health-guides/a-guide-to-green-lipped-mussel

For a video explaining how Lyprinol works. click here:

https://www.youtube.com/watch?v=0PRhUKZTPDo

Mussel oil extract could help sufferers of osteoarthritis – Mail on Sunday

Patients flex their mussels for pain relief: Clam oil extract could help millions

  • Mussel oil extract could help sufferers of osteoarthritis
  • Reduced joint pain by 89 per cent during tests on patients
  • Of the 8.5m sufferers in the UK, 71 per cent are in constant pain

A mussel oil extract could provide effective pain relief for the millions who suffer from osteoarthritis, new research suggests.

The supplement – extracted from New Zealand green-lipped mussels – was found to reduce pain in people with the degenerative condition by 89 per cent.

It also proved more effective than traditional fish oils at easing symptoms.

Reef relief: Oil extracted from a specific type of mussel has been found to significantly reduce pain in people with osteoarthritis

‘These are remarkable findings, especially as no side effects were reported,’ says Professor Jacek Szechinski, who led the study.

Osteoarthritis is the most common form of arthritis, with about 8.5 million sufferers in the UK.

It causes inflammation and damage around the joints, often leading to stiffness and severe pain. According to Arthritis Care, 71 per cent of sufferers are in constant pain.

Common pain: About 8.5million people suffer from osteoarthritis in the UK

The new study, published in the Marine Drugs journal, compared the supplement Lyprinol, which uses a patented extract process that preserves mussels’ potent lipids, with fish oil commonly taken for the condition.

Researchers at Poland’s Clinic of Rheumatology and Internal Medicine tested 50 adults with osteoarthritis in the knee or hip.

For 12 weeks, half the group was given Lyprinol (1,200 mg daily) and half a traditional fish oil supplement.

The pain assessment scores for those on mussel oil showed a significant improvement within four weeks and 91 per cent reported an improved quality of life.

Those on fish oil showed no such reduction in pain or improved mobility.

‘This could potentially mark a major breakthrough,’ says consultant rheumatologist Dr Sundeept Bhalara from Spire Bushey Hospital, Hertfordshire.

Home

Article here:
http://www.dailymail.co.uk/health/article-2357326/Patients-flex-mussels-pain-relief-Clam-oil-extract-help-millions.html

Asthma breakthrough?

Australian Current Affair

http://aca.ninemsn.com.au/article.aspx?id=8677790

The Beat goes On – Professor Mickelborough Interview

Dr Colbert Article

http://www.drcolbert.com/blog/?p=283

NEW HOPE IN OSTEOARTHRITIS PAIN BATTLE

STUDY FINDS MUSSEL OIL CAN REDUCE SYMPTOMS BY 89%

AN OIL found in New Zealand mussels could free millions of osteoarthritis sufferers from the constant, sometimes crippling pain of their condition, according to new research.

A team from the Clinic of Rheumatology and Internal Medicine in Poland found that the oil, called PCSO-524, reduced arthritis-related pain by 89%, with 91% of participants reporting an improved quality of life. The oil is the active ingredient in Lyprinol.

The study also found that traditional fish oil supplements were less effective, with patients reporting higher pain levels throughout the trial.

Professor Jacek Szechiński, who led the study, said:

“These are remarkable findings, which show that the mussel oil PCSO-524 is significantly more effective than traditional fish oils in treating the pain associated with osteoarthritis. As there are no side effects due to the lower dosages than are needed compared to traditional fish oils, Lyprinol could offer an effective alternative treatment to those people whose life is blighted by the pain of osteoarthritis.

“With the results of this study, and previous work which has shown the benefits of PCSO-524, it’s starting to look like we’ve only scratched the surface of what this oil has to offer to those suffering from not just osteoarthritis but a range of conditions. It’s a very exciting time.”

The study is published in the Special Issue ‘Marine Compounds and Inflammation’ of the Marine Drugs journal (Zawadzki et al 2013; Mar. Drugs 2013, 11 (6), 1920-1935; doi: 10 3390/md11061920)

Click here to download Professor Szechiński- OSTEOARTHRITIS Study

Asthma Breakthrough!

NEW HOPE FOR MILLIONS OF ASTHMA SUFFERERS

MUSSEL OIL IN LYPRINOL SLASHES DEPENDENCE ON INHALERS BY 83%

AN oil discovered in New Zealand mussels by British scientists in the 1980s could offer new hope to millions of asthma sufferers around the world, according to groundbreaking new research.

The study, led by Professor Timothy D. Mickleborough at Indiana University, found that the oil from New Zealand mussels – found only in Lyprinol – reduced dependence on inhalers by a staggering 83 per cent and improved the lung function of asthmatics who suffer from exercise-induced attacks by 59 per cent.

The oil, called PCSO-524, was first discovered by Dr Sheila Gibson and used to treat arthritis-related inflammation at Glasgow’s Victoria Infirmary in 1980. Today, Lyprinol is commonly used to support joint health and reduce inflammation related to conditions including arthritis. It is the only product available that contains PCSO-524.

Prof Mickleborough said:
“These findings are a real breakthrough, and offer new hope for asthma sufferers all over the world. Reducing the dependence on inhalers will offer those who suffer from asthma a new freedom, while the ability to lower the risk of exercise-induced asthma attacks will allow sufferers to increase their health and pursue their athletic ambitions more freely.

“We already know the benefits of Lyprinol in joint health and inflammation, but this new study indicates that this supplement- and the mussel oil PCSO-524 offers more health-giving potential than we previously thought. It’s a hugely exciting time.”

Prof Mickleborough’s study will be published in a forthcoming issue of the peer-reviewed British journal, Respiratory Medicine. It is also available online: http://bit.ly/10oZJEk